The global NGS Target Enrichment Solutions market size is predicted to grow from US$ 1157 million in 2025 to US$ 2688 million in 2031; it is expected to grow at a CAGR of 15.1% from 2025 to 2031.

NGS Target Enrichment Solutions refer to a set of technologies and methods used to selectively capture and enrich specific regions of DNA or RNA for sequencing in NGS applications. These solutions involve techniques such as hybridization capture, PCR-based amplification, or bead-based enrichment to isolate regions of interest (such as genes or genetic mutations) from a larger genome before sequencing. By focusing on specific targets, these solutions improve sequencing efficiency, reduce costs, and increase the depth of coverage for the regions being studied. They are commonly used in genomic research, clinical diagnostics, and personalized medicine to analyze particular genetic variants, mutations, or disease-related regions with high precision.

United States market for NGS Target Enrichment Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for NGS Target Enrichment Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for NGS Target Enrichment Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key NGS Target Enrichment Solutions players cover Thermo Fisher Scientific, Illumina, Agilent Technologies, QIAGEN, Integrated DNA Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “NGS Target Enrichment Solutions Industry Forecast” looks at past sales and reviews total world NGS Target Enrichment Solutions sales in 2024, providing a comprehensive analysis by region and market sector of projected NGS Target Enrichment Solutions sales for 2025 through 2031. With NGS Target Enrichment Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NGS Target Enrichment Solutions industry.

This Insight Report provides a comprehensive analysis of the global NGS Target Enrichment Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NGS Target Enrichment Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NGS Target Enrichment Solutions market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NGS Target Enrichment Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NGS Target Enrichment Solutions.

This report presents a comprehensive overview, market shares, and growth opportunities of NGS Target Enrichment Solutions market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Multiplex PCR-based (Amplicon Sequencing)
    Hybrid Capture-based

Segmentation by Application:

    Hospitals and Clinics
    Biopharma Companies
    Academic and Research Organizations
    Others

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Thermo Fisher Scientific
    Illumina
    Agilent Technologies
    QIAGEN
    Integrated DNA Technologies
    Twist Bioscience
    Takara Bio
    GenScript
    Roche Sequencing Solutions
    Oxford Gene Technology
    Pillar Biosciences
    Celemics
    Daicel Arbor Biosciences
    Nonacus
    Tecan
    Cantata Bio
    Paragon Genomics
    New England Biolabs
    Shanghai Dynegene Technologies